These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6178407

  • 1. Similar level of metabolic activation of benzo(a)pyrene in perfused rat lung and liver and protection of lung by liver in a combined perfusion system.
    Klaus E, Foth H, Kahl R, Kahl GF.
    Biochem Biophys Res Commun; 1982 Mar 30; 105(2):596-602. PubMed ID: 6178407
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW, Kauffman FC, Thurman RG.
    Cancer Res; 1984 Nov 30; 44(11):5073-8. PubMed ID: 6488167
    [Abstract] [Full Text] [Related]

  • 3. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
    Wiersma DA, Roth RA.
    J Pharmacol Exp Ther; 1983 Apr 30; 225(1):121-5. PubMed ID: 6300370
    [Abstract] [Full Text] [Related]

  • 4. Formation of benzo[a]pyrene metabolite-nucleoside adducts in isolated perfused rat and mouse liver and in mouse lung slices.
    Kahl GF, Klaus E, Legraverend C, Nebert DW, Pelkonen O.
    Biochem Pharmacol; 1979 Apr 01; 28(7):1051-6. PubMed ID: 444261
    [No Abstract] [Full Text] [Related]

  • 5. Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration.
    Foth H, Mollière M, Kahl R, Jähnchen E, Kahl GF.
    Drug Metab Dispos; 1984 Apr 01; 12(6):760-6. PubMed ID: 6150827
    [Abstract] [Full Text] [Related]

  • 6. Binding of benzo(a)pyrene to rat liver nuclear matrix.
    Ueyama H, Matsuura T, Nomi S, Nakayasu H, Ueda K.
    Life Sci; 1981 Aug 17; 29(7):655-61. PubMed ID: 6168881
    [No Abstract] [Full Text] [Related]

  • 7. The formation of benzo [a] pyrene - deoxyribonucleoside adducts in vivo and in vitro.
    Ashurst SW, Cohen GM.
    Carcinogenesis; 1982 Aug 17; 3(3):267-73. PubMed ID: 6282487
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modulation of epoxide hydrolase activity; effect on the activation of benzo[a] pyrene and its covalent binding to DNA in the nucleus.
    Guenthner TM, Oesch F.
    Adv Exp Med Biol; 1981 Aug 17; 136 Pt A():705-16. PubMed ID: 6283816
    [No Abstract] [Full Text] [Related]

  • 12. Kinetics of uptake and biliary excretion of benzo(alpha)pyrene and mutagenic metabolites in isolated perfused rat liver.
    Forti GC, Trieff NM.
    Teratog Carcinog Mutagen; 1980 Aug 17; 1(3):269-82. PubMed ID: 6119817
    [Abstract] [Full Text] [Related]

  • 13. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data.
    Wiersma DA, Roth RA.
    Mol Pharmacol; 1983 Sep 17; 24(2):300-8. PubMed ID: 6310365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition by 17-alpha-ethinyl estradiol of benzo[a]-pyrene metabolism in isolated adult rat hepatocytes.
    Benrekassa J, Decloitre F.
    Biochem Pharmacol; 1983 Jan 15; 32(2):347-53. PubMed ID: 6307317
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism and DNA binding of benzo(a)pyrene in vivo in the rat.
    Boroujerdi M, Kung H, Wilson AG, Anderson MW.
    Cancer Res; 1981 Mar 15; 41(3):951-7. PubMed ID: 7459882
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.